4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-23-002184
Chief Medical Officer sold 2,913 shares at $28.69 ($83,574)
- Chief Medical Officer acquired 41,120 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2023-01-03 | Grant or award | +41,120 | 138,967 | D | ||
| Ho Carole Chief Medical Officer | 2023-01-04 | Sale | −2,913 | $28.69 | $83,574 | 175,500 | I |
| Derivatives | |||||||
| Ho Carole Chief Medical Officer | 2023-01-03 | Grant or award · Stock Option (right to buy) | +123,360 | 123,360 | D | ||
| Open-market sales · 2,913 sh · avg $28.69 · $83,574 | |||||||
Loading xslF345X03/doc4.xml…